Attached files

file filename
EX-21.01 - EXHIBIT 21.01 - Tonix Pharmaceuticals Holding Corp.v402310_ex21-01.htm
EX-10.16 - EXHIBIT 10.16 - Tonix Pharmaceuticals Holding Corp.v402310_ex10-16.htm
EX-31.01 - EXHIBIT 31.01 - Tonix Pharmaceuticals Holding Corp.v402310_ex31-01.htm
EXCEL - IDEA: XBRL DOCUMENT - Tonix Pharmaceuticals Holding Corp.Financial_Report.xls
EX-32.01 - EXHIBIT 32.01 - Tonix Pharmaceuticals Holding Corp.v402310_ex32-01.htm
10-K - FORM 10-K - Tonix Pharmaceuticals Holding Corp.v402310_10k.htm
EX-31.02 - EXHIBIT 31.02 - Tonix Pharmaceuticals Holding Corp.v402310_ex31-02.htm

 

Exhibit 23.01

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in the Registration Statements [Form S-3 No. 333-192541 and Form S-8 No. 333-202006] of Tonix Pharmaceuticals Holding Corp. of our report dated February 27, 2015, with respect to the consolidated financial statements of Tonix Pharmaceuticals Holding Corp. and our report dated February 27, 2015 with respect to the effectiveness of Tonix Pharmaceuticals Holding Corp.’s internal controls over financial reporting included in this Annual Report on Form 10-K for the year ended December 31, 2014.

 

/s/ EisnerAmper LLP

 

New York, New York

February 27, 2015